Patents by Inventor Charles Good

Charles Good has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclicsulfonamide hepatitis C virus inhibitors
    Publication number: 20040072761
    Abstract: The present invention relates to tripeptide compounds, compositions containing such compounds and methods for using such compounds for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Application
    Filed: May 20, 2003
    Publication date: April 15, 2004
    Inventors: Jeffrey Allen Campbell, Andrew Charles Good
  • Hepatitis C virus inhibitors
    Publication number: 20040048802
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Application
    Filed: May 20, 2003
    Publication date: March 11, 2004
    Inventors: Amy Ripka, Jeffrey Allen Campbell, Andrew Charles Good, Paul Michael Scola, Ny Sin, Brian Venables
  • Inhibitors of hepatitis C virus
    Publication number: 20040038872
    Abstract: The present invention relates to macrocyclic compounds, methods for making these compounds, pharmaceutical compositions and the therapeutic or prophylactic use of these compounds by administering said compounds to mammals to prevent or treat hepatitis C virus (HCV) infection.
    Type: Application
    Filed: December 12, 2002
    Publication date: February 26, 2004
    Inventors: Jeffrey Allen Campbell, Andrew Charles Good